Profile
Full Name
Kura Oncology, Inc.Ticker Symbol
KURAExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
September 16, 2015Indexes
Not includedWebsite
http://kuraoncology.comEmployees
192Key Details
Price
$6.43(0.00%)
Market cap
$519.25M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$53.88M
Annual EPS
-$2.02(+2.88% YoY)
PE ratio
-
Next earnings date
May 1, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Kura Oncology doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 6, 25 UBS
BuyFeb 27, 25 HC Wainwright & Co.
BuyFeb 6, 25 Wedbush
OutperformFeb 6, 25 JMP Securities
Market OutperformFeb 6, 25 HC Wainwright & Co.
BuyJan 8, 25 Scotiabank
Sector PerformDec 9, 24 Cantor Fitzgerald
OverweightNov 26, 24 Cantor Fitzgerald
OverweightNov 22, 24 B of A Securities
BuyNov 21, 24 TD Cowen
BuyInstitutional Ownership
- What is the ticker symbol for Kura Oncology?
- Does Kura Oncology pay dividends?
- What sector is Kura Oncology in?
- What industry is Kura Oncology in?
- What country is Kura Oncology based in?
- When did Kura Oncology go public?
- Is Kura Oncology in the S&P 500?
- Is Kura Oncology in the NASDAQ 100?
- Is Kura Oncology in the Dow Jones?
- When was Kura Oncology's last earnings report?
- When does Kura Oncology report earnings?
- Should I buy Kura Oncology stock now?
What is the ticker symbol for Kura Oncology?
The ticker symbol for Kura Oncology is NASDAQ:KURA
Does Kura Oncology pay dividends?
No, Kura Oncology does not pay dividends
What sector is Kura Oncology in?
Kura Oncology is in the Healthcare sector
What industry is Kura Oncology in?
Kura Oncology is in the Biotechnology industry
What country is Kura Oncology based in?
Kura Oncology is headquartered in United States
When did Kura Oncology go public?
Kura Oncology's initial public offering (IPO) was on September 16, 2015
Is Kura Oncology in the S&P 500?
No, Kura Oncology is not included in the S&P 500 index
Is Kura Oncology in the NASDAQ 100?
No, Kura Oncology is not included in the NASDAQ 100 index
Is Kura Oncology in the Dow Jones?
No, Kura Oncology is not included in the Dow Jones index
When was Kura Oncology's last earnings report?
Kura Oncology's most recent earnings report was on Feb 26, 2025
When does Kura Oncology report earnings?
The next expected earnings date for Kura Oncology is May 1, 2025
Should I buy Kura Oncology stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions